课题基金 / 基金详情

Dissecting SARS-CoV-2 infection in Down syndrome with congenital heart defects using patient-specific iPSCs

Dissecting SARS-CoV-2 infection in Down syndrome with congenital heart defects using patient-specific iPSCs
使用患者特异性 iPSC 剖析患有先天性心脏缺陷的唐氏综合症患者的 SARS-CoV-2 感染
批准号:
10698064
负责人:
Mingtao Zhao
金额:
$19.5万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-06 至 2024-07-31

项目摘要

项目成果

Mingtao Zhao的其他基金

相似基金

相关文献

中文摘要
翻译
唐氏综合症(DS)是最常见的遗传性疾病,大约每800个活产婴儿中就有1个患有唐氏综合症
英文摘要
Down syndrome (DS) is the most common genetic disorder occurring in about 1 in 800 live births, and is characterized by a distinctive facial appearance, intellectual disability, and developmental delays. Gene dosage imbalance in DS patients, primarily caused by an extra copy of chromosome 21 (trisomy 21), is thought to contribute to a broad spectrum of coexisting medical conditions. DS is frequently associated with congenital heart defects (CHDs); approximately 40% of DS patients have some form of CHD, with atrioventricular septal defects (AVSD) being the most prevalent. The swift global spread of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the ongoing pandemic. Intriguingly, DS patients are more vulnerable to SARS-CoV-2 infection: there is a 4-fold increased risk for COVID- 19-related hospitalization and a 10-fold higher risk for COVID-19-related death compared to patients without DS. Mechanisms by which individuals with DS are more susceptible to COVID-19 are largely unknown. Genetically engineered mice made trisomic for homologous chromosome 16 (MMU16) were developed to study genotype- phenotype correlations in DS. However, because authentic SARS-CoV-2 is unable to infect mice due to the inefficient interaction between the viral S-protein and the mouse orthologue of its receptor, human angiotensin converting enzyme 2 (ACE2), it is not ideal to recapitulate SARS-CoV-2 infection in DS patients using current DS mouse models. In this R21 proposal, we aim to bridge this knowledge gap by dissecting the mechanistic causes of the susceptibility of DS patients to COVID-19 using patient-specific induced pluripotent stem cells (iPSCs). Some genes encoded by chromosome 21 (e.g. transmembrane proteinase serine 2, TMPRSS2) are dysregulated in individuals with DS and have been implicated to have a role in SARS-CoV-2 infection. Our central hypothesis is that upregulation of TMPRSS2 in DS leads to enhanced SARS-CoV-2 infection in the lungs, resulting in an enhanced cytokine surge that increases the severity of COVID-19. In Specific Aim 1, we will elucidate the mechanisms underlying the enhanced cytokine surge in Down syndrome in response to SARS- CoV-2 infection using DS iPSC-derived lung organoids. In Specific Aim 2, we will determine the gene-dosage effect of TMPRSS2 on SARS-CoV-2 infection in DS iPSC-derived cardiac and endothelial cells. It is expected that this project will have a major impact on the understanding of susceptibility of DS patients to SARS-CoV-2 infection using clinically relevant and patient-specific cardiac and lung cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease
An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease
An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease
An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease
国内基金
海外基金
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
  • 批准号:
    JCZRLH202600625
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
  • 批准号:
    2026JJ50619
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    翁春艳
  • 依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介 导“肠-胰岛 ”轴血糖调控功能的降糖机制研 究
  • 批准号:
    Y24H280055
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    颜美秋
  • 依托单位: